Showing all 10 results
Celecoxib Capsules
FreeCelecoxib capsules are selective non-steroidal anti-inflammatory drugs (NSAIDs) used to manage pain and inflammation. They are commonly available in strengths of 50 mg, 100 mg, 200 mg, and 400 mg.
Cyclophosphamide Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.
Active Ingredient Strength Primary Use Cyclophosphamide USP/BP 200 mg Vial Low Dose / Autoimmune Cyclophosphamide USP/BP 500 mg Vial Standard Chemotherapy Cyclophosphamide USP/BP 1000 mg (1 g) Vial High Dose / Hematology Excipients Mannitol / Sodium Chloride Bulking Agent (For Cake Structure) *Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.
Diacerein Capsules
FreeDiacerein capsules are a slow-acting treatment primarily used for osteoarthritis of the knee and hip. They work by inhibiting Interleukin-1 (IL-1), a protein that plays a major role in joint inflammation and the destruction of cartilage.
Glucosamine Capsule
FreeGlucosamine capsules typically contain one or more forms of glucosamine, an amino sugar essential for building cartilage and joint tissues. These active ingredients are often derived from the shells of shellfish (crabs, shrimp, and lobsters) or produced from vegetarian sources like fermented corn or fungi.
Indomethacin Capsules
FreeIndomethacin capsules contain the active nonsteroidal anti-inflammatory drug (NSAID) and a few standard pharmaceutical fillers to ensure the medication is delivered effectively
Leflunomide Tablets
FreeProduct Composition & Available Portfolio Strengths
We supply Leflunomide across the complete compendial strength matrix, enabling clinicians to manage both rapid initial loading cycles and long-term low-dose maintenance blocks.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Application Leflunomide USP / BP / IP 10 mg Oral Solid Film-Coated Tablet Low-Dose Maintenance: Calibrated for mild-to-moderate maintenance blocks or patients exhibiting sensitive hepatic profiles. Leflunomide USP / BP / IP 20 mg Oral Solid Film-Coated Tablet The Core Commercial Volume: First-line international standard daily maintenance dose for active Rheumatoid and Psoriatic Arthritis. Leflunomide USP / BP / IP 100 mg Oral High-Mass Solid Tablet Initial Loading Regimen: High-potency format utilized exclusively for the rapid 3-day initial tissue saturation phase. Methotrexate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Isotonic Solution (Ready-to-Use) or Lyophilized Powder (High Dose).
Active Ingredient Strength Common Application Methotrexate USP/BP 2.5 mg / ml Low Dose (Rheumatology/Dermatology) Methotrexate USP/BP 25 mg / ml Standard Oncology Dose Methotrexate USP/BP 50 mg / 500 mg / 1 g High Dose MTX (Leukemia Protocols) Preservative Benzyl Alcohol Present in Multi-dose Vials (Avoid in IT use) *Pack Sizes: 2 ml Vial, 20 ml Vial, or 50 ml Vial.
Methylprednisolone Sodium Succinate Injection
FreeProduct Composition & Strength
We supply this product as a Sterile Lyophilized Powder requiring reconstitution with the provided solvent.
Active Ingredient Strength Standard Use Methylprednisolone Sod. Succ. 40 mg Local Injection / Minor Allergic Reaction Methylprednisolone Sod. Succ. 125 mg Acute Asthma / Status Asthmaticus Methylprednisolone Sod. Succ. 500 mg / 1000 mg (1 gm) Pulse Therapy (Lupus / Transplant Rejection) Diluent Bacteriostatic Water Provided with Act-O-Vial or Separate Ampoule *Pack Sizes: Single Vial with Diluent.
Methylprednisolone Tablet
FreeProduct Composition & Available Strengths
We supply Methylprednisolone in a comprehensive, internationally standardized range of strengths to facilitate both low-dose chronic maintenance and the high-dose taper packs mandatory in clinical steroid therapy.
Active Ingredient Monograph Available Strengths Formulation Matrix Delivery System Primary Clinical Target Methylprednisolone USP / BP / IP 4 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Baseline Dose / Tapering: For rheumatoid arthritis maintenance and step-down dose regimens. Methylprednisolone USP / BP / IP 8 mg Oral Solid Uncoated Tablet (Cross-scored for micro-titration) Intermediate Management: For moderate asthma exacerbations and chronic dermatological conditions. Methylprednisolone USP / BP / IP 16 mg Oral Solid Uncoated Tablet (Cross-scored for flexible division) High-Potency Control: For acute autoimmune flares, immunosuppression in organ transplants, and oncology support. Triamcinolone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Uncoated Tablet, packed in highly secure, moisture-resistant Alu-PVC or opaque Alu-Alu blister strips to preserve the integrity of the steroidal API across high-humidity tropical climates.
Active Ingredient Strength Primary Clinical Use Triamcinolone IP/USP/BP 4 mg Standard Clinical Dose: Maintenance and flare-reduction therapy for severe inflammatory, allergic, and autoimmune disorders. Excipients Lactose Monohydrate / Magnesium Stearate / Microcrystalline Cellulose Diluent / Lubricant (Engineered for optimal compressibility and rapid gastric dispersion)
